Target intelligence / Profile preview

Daboia siamensis serine protease venom toxins (SVSPs)

Target
SVSPs
Molecular classification
Enzyme, Serine protease, Hydrolase
01

Overview

Daboia siamensis serine protease venom toxins (SVSPs) are a group of enzymatic proteins found in the venom of the Eastern Russell's viper, a snake of significant medical importance in Southeast Asia. These toxins primarily act on the host's hemostatic system, functioning as procoagulants that trigger the blood clotting cascade. Key members include Factor V activators, such as RVV-V, and thrombin-like enzymes that directly cleave fibrinogen into fibrin. This enzymatic activity leads to the formation of weak, friable clots and the rapid depletion of essential clotting factors. The resulting condition, known as venom-induced consumption coagulopathy (VICC), causes systemic hemorrhage and can lead to fatal complications like acute kidney injury or pituitary infarction. Therapeutically, these toxins are the primary targets for specific monovalent and polyvalent antivenoms, which neutralize their proteolytic activity through antibody binding. Beyond their role in envenomation, SVSPs are studied as templates for the development of novel anticoagulant drugs and diagnostic reagents for coagulation disorders. Effective management of envenomation requires early administration of antivenom to prevent the irreversible consumption of coagulation factors.

Other names
Snake venom serine proteasesSVSPsRussell's viper venom serine proteasesRVV-VFactor V activatorRVAFRVBFThrombin-like enzymes
02

Mechanism of action

Neutralization of enzymatic activity through antibody binding

03

Biological functions

ProteolysisBlood coagulation cascade activationFibrinogenolysisProcoagulant activity
04

Disease associations

Snakebite envenomationVenom-induced consumption coagulopathyHemorrhageAcute kidney injuryPituitary hemorrhage
05

Safety considerations

Antivenom-induced anaphylaxisSerum sicknessIncomplete neutralization of toxinsRapid onset of systemic coagulopathy
06

Interacting drugs

Daboia siamensis Monovalent Antivenom

1 more in the full profile.

07

Biomarkers

Prothrombin timeActivated partial thromboplastin timeFibrinogen levelD-dimerFactor V activity

Beyond the preview

Go deeper on Daboia siamensis serine protease venom toxins (SVSPs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daboia siamensis serine protease venom toxins (SVSPs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call